Definitive Healthcare (DH) Stock Forecast, Price Target & Predictions
DH Stock Forecast
Definitive Healthcare stock forecast is as follows: an average price target of $9.50 (represents a 100.42% upside from DH’s last price of $4.74) and a rating consensus of 'Hold', based on 12 wall street analysts offering a 1-year stock forecast.
DH Price Target
The average price target for Definitive Healthcare (DH) is $9.50 based on 1-year price targets from 12 Wall Street analysts in the past 3 months, with a price target range of $30.00 to $4.00. This represents a potential 100.42% upside from DH's last price of $4.74.
DH Analyst Ratings
According to 12 Wall Street analysts, Definitive Healthcare's rating consensus is 'Hold'. The analyst rating breakdown for DH stock is 0 'Strong Buy' (0.00%), 5 'Buy' (41.67%), 6 'Hold' (50.00%), 1 'Sell' (8.33%), and 0 'Strong Sell' (0.00%).
Definitive Healthcare Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 17, 2024 | David Larsen | BTIG | $7.00 | $4.44 | 57.66% | 47.68% |
| Aug 09, 2024 | George Hill | Deutsche Bank | $5.00 | $3.87 | 29.20% | 5.49% |
| Aug 07, 2024 | Saket Kalia | Barclays | $4.00 | $3.65 | 9.59% | -15.61% |
| Aug 06, 2024 | Craig Hettenbach | Morgan Stanley | $5.00 | $3.72 | 34.41% | 5.49% |
| Aug 05, 2024 | Kash Rangan | Goldman Sachs | $8.00 | $3.55 | 125.35% | 68.78% |
| Jul 31, 2024 | David Grossman | Stifel Nicolaus | $7.50 | $3.41 | 119.94% | 58.23% |
| May 09, 2024 | Saket Kalia | Barclays | $7.00 | $5.35 | 30.84% | 47.68% |
| May 08, 2024 | George Hill | Deutsche Bank | $7.00 | $5.35 | 30.84% | 47.68% |
| Jan 06, 2023 | - | Morgan Stanley | $18.00 | $10.57 | 70.29% | 279.75% |
| Aug 08, 2022 | - | Morgan Stanley | $34.00 | $25.78 | 31.89% | 617.30% |
The latest Definitive Healthcare stock forecast, released on Sep 17, 2024 by David Larsen from BTIG, set a price target of $7.00, which represents a 57.66% increase from the stock price at the time of the forecast ($4.44), and a 47.68% increase from DH last price ($4.74).
Definitive Healthcare Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 6 | 8 |
| Avg Price Target | $7.00 | $6.08 | $6.31 |
| Last Closing Price | $4.74 | $4.74 | $4.74 |
| Upside/Downside | 47.68% | 28.27% | 33.12% |
In the current month, the average price target of Definitive Healthcare stock is $7.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 47.68% increase as opposed to Definitive Healthcare's last price of $4.74. This month's average price target is up 15.13% compared to last quarter, and up 10.94% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 17, 2024 | BTIG | - | Buy | Initialise |
| Aug 09, 2024 | Deutsche Bank | Hold | Hold | Hold |
| Aug 07, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
| Aug 06, 2024 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
| Aug 05, 2024 | Goldman Sachs | Neutral | Neutral | Hold |
| May 09, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
| May 08, 2024 | Deutsche Bank | Hold | Hold | Hold |
| Feb 29, 2024 | Canaccord Genuity | Positive | Positive | Hold |
| Jan 17, 2024 | William Blair | Outperform | Outperform | Hold |
| Aug 15, 2023 | UBS | Outperform | Outperform | Hold |
Definitive Healthcare's last stock rating was published by BTIG on Sep 17, 2024. The company Initialise its DH rating from "null" to "Buy".
Definitive Healthcare Financial Forecast
Definitive Healthcare Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $65.33M | $60.96M | $59.20M | $60.60M | $57.38M | - | $50.12M | $46.31M | $43.08M |
| Avg Forecast | $66.55M | $66.05M | $65.25M | $64.64M | $64.80M | $63.93M | $62.71M | $61.85M | $60.27M | $61.62M | $63.10M | $63.99M | $66.00M | $63.70M | $61.04M | $57.58M | $58.45M | $56.67M | $53.76M | $48.52M | $44.70M | $41.15M |
| High Forecast | $66.92M | $66.41M | $65.61M | $64.99M | $65.16M | $64.28M | $63.05M | $62.19M | $60.60M | $61.90M | $63.45M | $64.34M | $66.16M | $64.05M | $61.37M | $57.90M | $58.78M | $56.98M | $53.76M | $49.53M | $45.63M | $42.01M |
| Low Forecast | $65.57M | $65.07M | $64.29M | $63.68M | $63.85M | $62.98M | $61.78M | $60.94M | $59.38M | $61.34M | $62.17M | $63.05M | $65.75M | $62.76M | $60.14M | $56.73M | $57.59M | $55.83M | $53.76M | $47.03M | $43.32M | $39.89M |
| # Analysts | 6 | 4 | 4 | 6 | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 5 | 3 | 7 | 4 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.03% | 1.00% | 1.03% | 1.04% | 1.01% | - | 1.03% | 1.04% | 1.05% |
Definitive Healthcare's average Quarter revenue forecast for Dec 23 based on 9 analysts is $66.00M, with a low forecast of $65.75M, and a high forecast of $66.16M. DH's average Quarter revenue forecast represents a 1.04% increase compared to the company's last Quarter revenue of $65.33M (Sep 23).
Definitive Healthcare EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 4 | 4 | 6 | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 5 | 3 | 7 | 4 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-148.09M | $7.05M | $4.00K | $5.39M | $12.23M | - | $5.48M | $8.13M | $6.51M |
| Avg Forecast | $16.81M | $16.68M | $16.48M | $16.33M | $16.37M | $16.15M | $15.84M | $15.62M | $15.22M | $15.56M | $15.94M | $7.80M | $16.67M | $16.09M | $15.42M | $7.09M | $14.77M | $21.27M | $13.58M | $6.45M | $8.13M | $19.34M |
| High Forecast | $16.90M | $16.78M | $16.57M | $16.42M | $16.46M | $16.24M | $15.93M | $15.71M | $15.31M | $15.64M | $16.03M | $9.36M | $16.71M | $16.18M | $15.50M | $8.51M | $14.85M | $25.53M | $13.58M | $7.74M | $9.75M | $23.20M |
| Low Forecast | $16.56M | $16.44M | $16.24M | $16.09M | $16.13M | $15.91M | $15.61M | $15.39M | $15.00M | $15.49M | $15.71M | $6.24M | $16.61M | $15.85M | $15.19M | $5.68M | $14.55M | $17.02M | $13.58M | $5.16M | $6.50M | $15.47M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | -9.20% | 0.46% | 0.00% | 0.36% | 0.58% | - | 0.85% | 1.00% | 0.34% |
4 analysts predict DH's average Quarter EBITDA for Sep 23 to be $16.09M, with a high of $16.18M and a low of $15.85M. This is 128.15% upper than Definitive Healthcare's previous annual EBITDA (Jun 23) of $7.05M.
Definitive Healthcare Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 4 | 4 | 6 | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 5 | 3 | 7 | 4 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $-171.53M | $-8.57M | $-15.60M | $6.74M | $-6.35M | - | $-13.06M | $-14.76M | $-15.79M |
| Avg Forecast | $3.40M | $3.58M | $3.20M | $3.08M | $8.98M | $8.82M | $8.37M | $7.77M | $7.23M | $8.17M | $10.08M | $-7.83M | $9.13M | $7.15M | $7.22M | $-7.11M | $4.94M | $-11.85M | $6.17M | $-6.47M | $-9.70M | $-10.77M |
| High Forecast | $3.42M | $3.60M | $3.22M | $3.10M | $9.05M | $8.89M | $8.43M | $7.83M | $7.28M | $8.23M | $10.15M | $-6.26M | $10.43M | $7.20M | $7.27M | $-5.69M | $4.97M | $-9.48M | $6.17M | $-5.17M | $-7.76M | $-8.62M |
| Low Forecast | $3.33M | $3.51M | $3.14M | $3.02M | $8.81M | $8.65M | $8.21M | $7.63M | $7.09M | $8.01M | $9.89M | $-9.39M | $7.82M | $7.01M | $7.08M | $-8.54M | $4.84M | $-14.22M | $6.17M | $-7.76M | $-11.64M | $-12.92M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | -23.98% | -1.19% | 2.19% | 1.36% | 0.54% | - | 2.02% | 1.52% | 1.47% |
Definitive Healthcare's average Quarter net income forecast for Mar 23 is $-7.11M, with a range of $-8.54M to $-5.69M. DH's average Quarter net income forecast represents a -205.64% decrease compared to the company's last Quarter net income of $6.74M (Dec 22).
Definitive Healthcare SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 4 | 4 | 6 | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 5 | 3 | 7 | 4 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $37.35M | $38.37M | $37.06M | $38.74M | $34.90M | - | $31.75M | $29.02M | $22.26M |
| Avg Forecast | $34.46M | $34.20M | $33.79M | $33.47M | $33.56M | $33.10M | $32.47M | $32.03M | $31.21M | $31.91M | $32.68M | $28.81M | $34.18M | $32.99M | $31.61M | $26.19M | $30.27M | $33.05M | $27.84M | $23.81M | $29.02M | $30.05M |
| High Forecast | $34.65M | $34.39M | $33.98M | $33.66M | $33.74M | $33.29M | $32.65M | $32.20M | $31.38M | $32.05M | $32.86M | $34.57M | $34.26M | $33.17M | $31.78M | $31.43M | $30.44M | $39.66M | $27.84M | $28.57M | $34.83M | $36.05M |
| Low Forecast | $33.95M | $33.70M | $33.29M | $32.98M | $33.06M | $32.61M | $31.99M | $31.56M | $30.75M | $31.76M | $32.19M | $23.05M | $34.05M | $32.50M | $31.14M | $20.95M | $29.82M | $26.44M | $27.84M | $19.05M | $23.22M | $24.04M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.13% | 1.21% | 1.42% | 1.28% | 1.06% | - | 1.33% | 1.00% | 0.74% |
Definitive Healthcare's average Quarter SG&A projection for Dec 23 is $34.18M, based on 9 Wall Street analysts, with a range of $34.05M to $34.26M. The forecast indicates a -8.49% fall compared to DH last annual SG&A of $37.35M (Sep 23).
Definitive Healthcare EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 4 | 4 | 6 | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 5 | 3 | 7 | 4 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-1.50 | $-0.08 | $-0.14 | $0.06 | $-0.06 | - | $-0.13 | $-0.16 | $-0.18 |
| Avg Forecast | $0.03 | $0.03 | $0.03 | $0.03 | $0.08 | $0.07 | $0.07 | $0.07 | $0.06 | $0.07 | $0.09 | $0.08 | $0.08 | $0.06 | $0.06 | $0.04 | $0.04 | $0.05 | $0.05 | $0.04 | $0.04 | $0.01 |
| High Forecast | $0.03 | $0.03 | $0.03 | $0.03 | $0.08 | $0.08 | $0.07 | $0.07 | $0.06 | $0.07 | $0.09 | $0.08 | $0.09 | $0.06 | $0.06 | $0.05 | $0.04 | $0.05 | $0.05 | $0.04 | $0.04 | $0.01 |
| Low Forecast | $0.03 | $0.03 | $0.03 | $0.03 | $0.07 | $0.07 | $0.07 | $0.06 | $0.06 | $0.07 | $0.08 | $0.08 | $0.07 | $0.06 | $0.06 | $0.04 | $0.04 | $0.05 | $0.05 | $0.03 | $0.03 | $0.01 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | -24.70% | -1.25% | -3.13% | 1.53% | -1.31% | - | -3.67% | -4.55% | -25.93% |
According to 4 Wall Street analysts, Definitive Healthcare's projected average Quarter EPS for Mar 23 is $0.04, with a low estimate of $0.04 and a high estimate of $0.05. This represents a -30.23% decrease compared to DH previous annual EPS of $0.06 (Dec 22).
Definitive Healthcare Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| HCAT | Health Catalyst | $8.70 | $29.25 | 236.21% | Buy |
| FORA | Forian | $2.22 | $4.50 | 102.70% | Buy |
| CERT | Certara | $10.83 | $21.75 | 100.83% | Hold |
| DH | Definitive Healthcare | $4.74 | $9.50 | 100.42% | Hold |
| PRVA | Privia Health Group | $18.80 | $33.82 | 79.89% | Buy |
| SLP | Simulations Plus | $31.89 | $56.00 | 75.60% | Buy |
| PHR | Phreesia | $24.41 | $36.31 | 48.75% | Buy |
| EVH | Evolent Health | $30.54 | $44.00 | 44.07% | Buy |
| HQY | HealthEquity | $78.80 | $97.00 | 23.10% | Buy |
DH Forecast FAQ
Is Definitive Healthcare a good buy?
No, according to 12 Wall Street analysts, Definitive Healthcare (DH) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 41.67% of DH's total ratings.
What is DH's price target?
Definitive Healthcare (DH) average price target is $9.5 with a range of $4 to $30, implying a 100.42% from its last price of $4.74. The data is based on 12 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Definitive Healthcare stock go up soon?
According to Wall Street analysts' prediction for DH stock, the company can go up by 100.42% (from the last price of $4.74 to the average price target of $9.5), up by 532.91% based on the highest stock price target, and down by -15.61% based on the lowest stock price target.
Can Definitive Healthcare stock reach $7?
DH's average twelve months analyst stock price target of $9.5 supports the claim that Definitive Healthcare can reach $7 in the near future.
What is Definitive Healthcare's current price target trend?
1 Wall Street analyst forecast a $7 price target for Definitive Healthcare (DH) this month, up 47.68% from its last price of $4.74. Compared to the last 3 and 12 months, the average price target increased by 28.27% and increased by 33.12%, respectively.
What are Definitive Healthcare's analysts' financial forecasts?
Definitive Healthcare's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $253.29M (high $254.68M, low $249.55M), average EBITDA is $63.98M (high $64.33M, low $63.04M), average net income is $33.95M (high $34.2M, low $33.3M), average SG&A $131.16M (high $131.88M, low $129.22M), and average EPS is $0.288 (high $0.29, low $0.283). DH's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $262.49M (high $263.94M, low $258.62M), average EBITDA is $66.31M (high $66.67M, low $65.33M), average net income is $13.26M (high $13.35M, low $13M), average SG&A $135.92M (high $136.67M, low $133.92M), and average EPS is $0.113 (high $0.113, low $0.11).
Did the DH's actual financial results beat the analysts' financial forecasts?
Based on Definitive Healthcare's last annual report (Dec 2022), the company's revenue was $222.65M, beating the average analysts forecast of $217.39M by 2.42%. Apple's EBITDA was $33.77M, missing the average prediction of $56.07M by -39.77%. The company's net income was $-22.255M, beating the average estimation of $-7.212M by 208.59%. Apple's SG&A was $138.37M, beating the average forecast of $114.97M by 20.35%. Lastly, the company's EPS was $-0.22, missing the average prediction of $0.177 by -224.35%. In terms of the last quarterly report (Sep 2023), Definitive Healthcare's revenue was $65.32M, beating the average analysts' forecast of $63.7M by 2.55%. The company's EBITDA was $-148M, missing the average prediction of $16.09M by -1020.31%. Definitive Healthcare's net income was $-172M, missing the average estimation of $7.15M by -2498.40%. The company's SG&A was $37.35M, beating the average forecast of $32.99M by 13.22%. Lastly, the company's EPS was $-1.5, missing the average prediction of $0.0607 by -2569.70%